Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bernstein

Showing results (661-670 of 714) with videos related to

Pageof 72
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2020
Continued Evidence of the Impact of Rotavirus Vaccine in Children Less Than 3 Years of Age From the United States New Vaccine Surveillance Network: A Multisite Active Surveillance Program, 2006-2016Mary Allen Staat, Daniel C Payne, Natasha Halasa, et al.
Genome Announcements|June 20, 2015
Genome Sequence of Mycobacteriophage MindyWelkin H Pope, Nicholas I Bernstein, Christina S Fasolas, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adultsFelicia Scaggs Huang, David I Bernstein, Karen S Slobod, et al.
Science Translational Medicine|June 19, 2015
Vinculin network-mediated cytoskeletal remodeling regulates contractile function in the aging heartGaurav Kaushik, Alice Spenlehauer, Ayla O Sessions, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Science Translational Medicine|December 5, 2014
Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomesJames M Hill, Debra C Quenelle, Rhonda D Cardin, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Plos One|May 8, 2015
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trialJulie E Ledgerwood, Abbie R Bellamy, Robert Belshe, et al.
The Journal of Infectious Diseases|July 9, 2018
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled TrialNicholas Van Wagoner, Kenneth Fife, Peter A Leone, et al.
The Journal of Investigative Dermatology|September 18, 2009
Genetic and environmental risk factors for childhood eczema development and allergic sensitization in the CCAAPS cohortJocelyn M Biagini Myers, Ning Wang, Grace K LeMasters, et al.
Pageof 72

Showing results (661-670 of 714) with videos related to

Sort By:
Pageof 72
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2020
Continued Evidence of the Impact of Rotavirus Vaccine in Children Less Than 3 Years of Age From the United States New Vaccine Surveillance Network: A Multisite Active Surveillance Program, 2006-2016Mary Allen Staat, Daniel C Payne, Natasha Halasa, et al.
Genome Announcements|June 20, 2015
Genome Sequence of Mycobacteriophage MindyWelkin H Pope, Nicholas I Bernstein, Christina S Fasolas, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adultsFelicia Scaggs Huang, David I Bernstein, Karen S Slobod, et al.
Science Translational Medicine|June 19, 2015
Vinculin network-mediated cytoskeletal remodeling regulates contractile function in the aging heartGaurav Kaushik, Alice Spenlehauer, Ayla O Sessions, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Science Translational Medicine|December 5, 2014
Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomesJames M Hill, Debra C Quenelle, Rhonda D Cardin, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Plos One|May 8, 2015
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trialJulie E Ledgerwood, Abbie R Bellamy, Robert Belshe, et al.
The Journal of Infectious Diseases|July 9, 2018
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled TrialNicholas Van Wagoner, Kenneth Fife, Peter A Leone, et al.
The Journal of Investigative Dermatology|September 18, 2009
Genetic and environmental risk factors for childhood eczema development and allergic sensitization in the CCAAPS cohortJocelyn M Biagini Myers, Ning Wang, Grace K LeMasters, et al.
Pageof 72